Global Bioinformatics Market 2022
- Relatório de mercado
- EU IA: HB24672G
- Prazo de entrega: 1 Dia de negócios
- Marcação: Bioinformatics
Descrição
According to StrategyHelix, the global bioinformatics market is expected to increase by US$ 9.9 bilhão durante 2022-2028, expanding at a CAGR of 8.1% durante o período de previsão.
O relatório fornece dados atualizados sobre o tamanho do mercado para o período 2018-2021 e previsão para 2028 covering key market aspects like sales value for bioinformatics. The global bioinformatics market is segmented on the basis of solution, services and platforms, aplicativo, usuário final, and region. Based on solution, the global bioinformatics market is categorized into data analysis software and services, hardware and infrastructure, tools and database services. The tools and database services segment captured the largest share of the market in 2021. On the basis of services and platforms, the global bioinformatics market has been segmented into sequencing platforms, sequencing services. The sequencing platforms segment held the largest share of the global bioinformatics market in 2021 and is anticipated to hold its share during the forecast period. By application, the global bioinformatics market has been segmented into cheminformatics, genomics, metabolomics, pharmacogenomics, proteomics, transcriptomics, outros. Em 2021, the genomics segment made up the largest share of revenue generated by the bioinformatics market. Based upon end user, the global bioinformatics market is categorized into academic institutions, agriculture, clinical and medical, outros. Entre estes, the clinical and medical segment was accounted for the highest revenue generator in 2021. Geographically, the global bioinformatics market is segmented into Asia Pacific, Europa, América do Norte, Rest of the World (RoW).
The global bioinformatics market is highly competitive. The leading players in the bioinformatics market include Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corp., GVK Biosciences Pvt. Ltda, Illumina Inc., Ocimum Biosolutions Ltd., Thermo Fisher Scientific Inc.
O relatório é um recurso inestimável para empresas e organizações ativas neste setor. It provides a cohesive picture of the bioinformatics market to help drive informed decision making for industry executives, decisores políticos, acadêmico, e analistas.
Escopo do relatório
Solution: data analysis software and services, hardware and infrastructure, tools and database services
Services and platforms: sequencing platforms, sequencing services
Aplicativo: cheminformatics, genomics, metabolomics, pharmacogenomics, proteomics, transcriptomics, outros
Usuário final: academic institutions, agriculture, clinical and medical, outros
Região: Ásia-Pacífico, Europa, América do Norte, Rest of the World (RoW)
Anos considerados: este relatório cobre o período 2018 para 2028
Principais benefícios para as partes interessadas
– Get a comprehensive picture of the global bioinformatics market
– Identifique setores de crescimento e tendências para investimento
Índice
Papel 1. Introdução
– Escopo do estudo
– Período de estudos
– Escopo geográfico
– Metodologia de Pesquisa
Papel 2. Bioinformatics market overview
Papel 3. Market breakdown by solution
– Data analysis software and services
– Hardware and infrastructure
– Tools and database services
Papel 4. Market breakdown by services and platforms
– Sequencing platforms
– Sequencing services
Papel 5. Market breakdown by application
– Cheminformatics
– Genomics
– Metabolomics
– Pharmacogenomics
– Proteomics
– Transcriptomics
– Outros
Papel 6. Detalhamento do mercado por usuário final
– Academic institutions
– Agricultura
– Clinical and medical
– Outros
Papel 7. Market breakdown by region
– Ásia-Pacífico
– Europa
– América do Norte
– Rest of the World (RoW)
Papel 8. Principais empresas
– Agilent Technologies Inc.
– Becton, Dickinson and Company
– Bio-Rad Laboratories, Inc..
– Bio-Techne Corp.
– GVK Biosciences Pvt. Ltda
– Illumina Inc.
– Ocimum Biosolutions Ltd.
– Thermo Fisher Scientific Inc.
Sobre StrategyHelix
Isenção de responsabilidade
USD 650